Actual Medicinal Product (AMP) Sitagliptin 25mg tablets (Medihealth (Northern) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product.
- Provenance
-
This recommendation is based on the products Januvia 25mg tablets (MSD) and Sitagliptin 25mg tablets (Glenmark Pharmaceuticals Europe Ltd.
- Generic
- Sitagliptin
- Formulation
- Sitagliptin 25mg tablets
-
Sitagliptin
-
Sitagliptin 25mg tablets
-
Sitagliptin 25mg tablets (Medihealth (Northern) Ltd)
-
-